Cardiovascular Diseases Research in Kentucky
Cardiovascular Diseases Research (93.837) awarded $85.8 million to recipients in Kentucky in 89 grants from fiscal 2021 to 2025, 0.6% of the program's national total. The University of Kentucky Research Foundation received the most, $49.9 million.
- Awarded in Kentucky$85.8 million
- Awards89
- Share of the program0.6%
- Rank among states30th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 36 | $17.2 million |
| FY 2022 | 36 | $14.8 million |
| FY 2023 | 39 | $15.2 million |
| FY 2024 | 38 | $17.6 million |
| FY 2025 | 42 | $20.9 million |
Recipients in Kentucky
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The University of Kentucky Research Foundation | Colleges and universities | 49 | $49.9 million |
| University of Louisville | Nonprofits | 29 | $29.4 million |
| W-Z Biotech LLC | Small businesses | 4 | $3.7 million |
| PGXL Technologies LLC | Small businesses | 2 | $1.4 million |
| Tele-Stethoscope Inc. | Small businesses | 2 | $598,822 |
| Aquilo Sports L.L.C | Small businesses | 1 | $350,681 |
| Degranin Therapeutics, LLC | Small businesses | 1 | $305,264 |
| Vcardio Inc. | Small businesses | 1 | $229,693 |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Kentucky?
$85.8 million from fiscal 2021 to 2025, across 89 awards. Kentucky ranks 30th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Kentucky?
The largest recipient is The University of Kentucky Research Foundation, with $49.9 million in 49 awards. Next are University of Louisville and W-Z Biotech LLC.
Can organizations in Kentucky apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Kentucky
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Broadband Equity, Access, and Deployment Program
- Head Start
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)